Abstract
Sex cord stromal cell tumours constitute 5-8 % of all ovarian neoplasms. Steroid cell tumours are a type of sex cord stromal cell tumours. The name “Steroid cell” stands for the morphology and the functionality of these tumours. Steroid cell tumours- Not otherwise specified constitute about 56% of all steroid cell tumours and presents more commonly with androgenic manifestations in third to fourth decade. We present a case, 22 year old, who presented with virilizing symptoms. MRI was suggestive of an right ovarian mass for which right salpingo-oophorectomy was done. Histopathology revealed features classical of Steroid cell tumour- Not otherwise specified. We present the case for a relatively younger age at presentation and the classical histomorphology. DOI:10.21276/APALM.1597
Highlights
Steroid cell tumour- NOS is a type of sex cord stromal cell tumour of the ovary
We present a case of a relatively younger female, 22 year old, who presented with virilizing symptoms
Microscopy of the ovarian tumour resected showed features classical of Steroid cell tumour- NOS type. We present this case to emphasize on the consideration of this entity in the clinical scenario of rapid onset of virilizing symptoms in a female and to document it’s occurrence at a younger age than the classical description in the literature
Summary
Steroid cell tumour- NOS is a type of sex cord stromal cell tumour of the ovary It presents usually in the third or the fourth decade of life with virilizing symptoms. Microscopy of the ovarian tumour resected showed features classical of Steroid cell tumour- NOS type. We present this case to emphasize on the consideration of this entity in the clinical scenario of rapid onset of virilizing symptoms in a female and to document it’s occurrence at a younger age than the classical description in the literature. (Range: 0.15-0.7 ng/ml) and the patient improved symptomatically This confirmed the source of excess androgen to be the ovarian tumour
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
